Team from Yale and Columbia Launch Website Mapping New Politics of Care
An interdisciplinary team of researchers at Columbia and Yale unveiled an interactive map on October 28, 2020 that guides policymakers and the public in deploying health care workers to communities most affected by the COVID-19 pandemic.
Rule of Law Clinic Publishes Guides to Protect Voters From Intimidation
Students from the Peter Gruber Rule of Law Clinic (ROLC) at Yale Law School, in conjunction with Campaign Legal Center (CLC), have published comprehensive guides for key states to protect the rights of voters and prevent voter intimidation.
Professor Witt Publishes New Book on American Contagions
In his new book, Professor John Fabian Witt ’99 explores the ways in which American law has shaped and responded to the experience of contagion throughout history.
New Book by Professor Ayres Seeks a New Way Forward on Gun Control to Save Lives
A new book by William K. Townsend Professor of Law Ian Ayres ’86 and coauthor Frederick E. Vars ’99 looks for a new way forward on gun control.
Liman Center and Partners: Plan Needed for CT Prisoner Votes to Count
The Arthur Liman Center for Public Interest Law at Yale Law School has joined with several organizations to propose immediate and long-term solutions to protect the voting rights of prisoners in Connecticut.
Yale committee to propose new fossil fuel investment principles
Sam Harris Professor of Corporate Law, Corporate Finance and Securities Law Jonathan R. Macey ’82 will chair a committee to guide Yale University as it evaluates its investment policies in relation to companies producing fossil fuels.
YLS Faculty and Students File Amicus Briefs in Nestle USA, Inc. v. Doe
Yale Law School faculty and students worked to submit two amicus briefs with the U.S. Supreme Court in the cases of Nestle USA, Inc. v. Doe and Cargill, Inc. v. Doe.
Open Letter Urges Transparency in COVID-19 Vaccine Clinical Trials
Students from the Media Freedom and Information Access (MFIA) Clinic, helped a nationwide group of medicine, public health, and health policy experts issue an open letter urging greater transparency into the design of clinical trials for COVID-19 vaccine candidates.